Business Dialogues| Pharma News and Business Healthcare News

facebook
twitter

facebook
twitter

Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
MD Brand Connect

News
blog

Home
News
blog

Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

Medical Dialogues Bureau14 April 2020 9:22 AM GMT

The raw materials which earlier used to cost Rs 9,000 per kilogram are now being sold at Rs 55,000-75,000

Top priority on Delivery of Medicines through Speed Post: Minister

Top priority on Delivery of Medicines through Speed Post: Minister

14 April 2020 8:10 AM GMT

Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

13 April 2020 10:18 AM GMT

Lupin gets USFDA EIR for Nagpur Facility

Lupin gets USFDA EIR for Nagpur Facility

13 April 2020 5:32 AM GMT

NPPA fixes prices of 29 formulations under DPCO, check out details

NPPA fixes prices of 29 formulations under DPCO, check out details

12 April 2020 8:07 AM GMT

Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

11 April 2020 7:48 AM GMT

Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

Medical Dialogues Bureau14 April 2020 9:46 AM GMT

Delhi: Indian Pharma industry is producing enough stocks of essential medicines particularly HCQ to meet both domestic demands and to meet export oblig...

Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

Medical Dialogues Bureau14 April 2020 8:15 AM GMT

Mumbai: The Joint Managing Director of Ipca Laboratories Ajit Kumar Jain on Saturday said that hydroxychloroquine is not approved as an anti-malarial d...

Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

Medical Dialogues Bureau14 April 2020 8:11 AM GMT

'The funding will allow us to invest further into improving patient outcomes and generate further real-world evidence while expanding our therapeutic...

Lasa Supergenerics gets FDA nod for Progesterone

Lasa Supergenerics gets FDA nod for Progesterone

Medical Dialogues Bureau14 April 2020 3:30 AM GMT

Mumbai: API producer, Lasa Supergenerics Ltd has forayed into the hormone and steroid API segment for Human application with its approval from the Food...

SMS Pharma updates against USFDA statement on Ranitidine

SMS Pharma updates against USFDA statement on Ranitidine

Medical Dialogues Bureau13 April 2020 9:01 AM GMT

India: Through a recent release with the exchanges, SMS Pharma has provided update against USFDA statement on RanitidineSMS Pharma is one of the m...

Implants / Devices

Hospital & Diagnostic

Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical...

Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

Capacit'e Infraprojects bags Rs 407 crore order in Mumbai

Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

• Email: info@medicaldialogues.in
• Phone: 011 - 4372 0751

Website Last Updated On : 27 May 2022 6:45 AM GMT

Company

About Us
Contact Us
Our Team
Reach our Editor
Feedback
Submit Article

Ads & Legal

Advertise
Advertise Policy
Terms and Conditions
Privacy Policy
Editorial Policy
Comments Policy
Disclamier

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search only trustworthy HONcode health websites:

Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

© 2020 - Medical Dialogues. All Rights Reserved.

Powered By: Hocalwire

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok

X

X